Page 42 - GTM-4-1
P. 42
Global Translational Medicine Phytonanotherapy in cancer and diabetes care
Biomater Sci Eng. 2022;8(5):1763-1790. delivery systems for emerging diagnosis and advanced
doi: 10.1021/acsbiomaterials.2c00026 therapy. Adv Mater. 2021;33(38):2102580.
91. Samavati SS, Kashanian S, Derakhshankhah H, Rabiei M. doi: 10.1002/adma.202102580
Nanoparticle application in diabetes drug delivery. 97. Yao J, Yang M, Duan Y. Chemistry, biology, and medicine of
J Nanoparticle Res. 2022;24(9):178. fluorescent nanomaterials and related systems: New insights
doi: 10.1007/s11051-022-05547-8 into biosensing, bioimaging, genomics, diagnostics, and
therapy. Chem Rev. 2014;114(12):6130-6178.
92. Mohammad G, Mishra VK, Pandey HP. Antioxidant
properties of some nanoparticle may enhance wound doi: 10.1021/cr200359p
healing in T2DM patient. Digest J Nanomater Biostruct. 98. Wu F, Liu J. Decorated bacteria and the application in drug
2008;3(4):159-162.
delivery. Adv Drug Deliv Rev. 2022;2022:114443.
93. Fu LH, Qi C, Lin J, Huang P. Catalytic chemistry of glucose doi: 10.1016/j.addr.2022.114443
oxidase in cancer diagnosis and treatment. Chem Soc Rev.
2018;47(17):6454-6472. 99. Xie J, Lee S, Chen X. Nanoparticle-based theranostic agents.
Adv Drug Deliv Rev. 2010;62(11):1064-1079.
doi: 10.1039/C7CS00891K
94. Li C, Wang J, Wang Y, et al. Recent progress in drug delivery. doi: 10.1016/j.addr.2010.07.009
Acta Pharm Sin B. 2019;9(6):1145-1162. 100. Luther DC, Huang R, Jeon T, et al. Delivery of drugs,
doi: 10.1016/j.apsb.2019.08.003 proteins, and nucleic acids using inorganic nanoparticles.
Adv Drug Deliv Rev. 2020;156:188-213.
95. Patra JK, Das G, Fraceto LF, et al. Nano based drug delivery
systems: Recent developments and future prospects. doi: 10.1016/j.addr.2020.06.020
J Nanobiotechnol. 2018;16(1):1-33. 101. Thakuria A, Kataria B, Gupta D. Nanoparticle-based
doi: 10.1186/s12951-018-0392-8 methodologies for targeted drug delivery-an insight.
J Nanoparticle Res. 2021;23:1-30.
96. Li Z, Wang Y, Liu J, Rawding P, Bu J, Hong S, Hu Q.
Chemically and biologically engineered bacteria‐based doi: 10.1007/s11051-021-05190-9
Volume 4 Issue 1 (2025) 34 doi: 10.36922/gtm.5840

